Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-20-002502
Filing Date
2020-06-24
Accepted
2020-06-24 16:38:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLULAR BIOMEDICINE GROUP, INC. p20-1201sc13da.htm SC 13D/A 124873
  Complete submission text file 0000902664-20-002502.txt   126736
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 20985892
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103 (345) 749-8643
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A